NAS:EIDX (USA) Also Trade In: Germany

Eidos Therapeutics Inc $ 122.21 0 (0%)

Volume:
0
Avg Vol (1m):
128,164
Market Cap $:
4.75 Bil
Enterprise Value $:
4.62 Bil
PE Ratio:
0.00
PB Ratio:
38.39
Warning! GuruFocus has detected 1 Severe warning sign with EIDX. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

Financial Strength

5/10
Current Vs Industry Vs History
Cash-To-Debt 6.86
Equity-to-Asset 0.76
Debt-to-Equity 0.18
Debt-to-EBITDA -0.22
N/A
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 71.46
DISTRESS
GREY
SAFE
Beneish M-Score -73.35
Not Manipulator
Manipulator
WACC vs ROIC
ROIC -984.66 %
WACC 7.46 %

Profitability Rank

Current Vs Industry Vs History
Operating Margin % -78625.2
Net Margin % -79392.91
ROE % -64.44
ROA % -53.67
ROC (Joel Greenblatt) % -1905.29
3-Year EBITDA Growth Rate -103.1
3-Year EPS without NRI Growth Rate -73

Valuation Rank

Current Vs Industry Vs History
PB Ratio 38.39
PS Ratio 40736.67
EV-to-EBIT -46.9
N/A
EV-to-EBITDA -47.03
N/A
EV-to-Revenue 36415.72
Current Ratio 11.1
Quick Ratio 11.1
Days Payable 347.63

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.8

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 38.43
Earnings Yield (Greenblatt) % -2.13